An international multicenter performance analysis of cytomegalovirus load tests

Clinical Infectious Diseases

Volumn 56, Issue 3, 2013, Pages 367-373

  Hirsch, Hans H ^a   Lautenschlager, Irmeli ^b   Pinsky, Benjamin A ^c   Cardeñoso, Laura ^d   Aslam, Shagufta ^e   Cobb, Bryan ^e   Vilchez, Regis A ^e   Valsamakis, Alexandra ^f  

^a UNIVERSITY OF BASEL   (Switzerland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c STANFORD UNIVERSITY   (United States)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e ROCHE MOLECULAR SYSTEMS   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

CMV; PCR; standardization; transplantation; viral load

Indexed keywords

ARTICLE; BLOOD SAMPLING; CALIBRATION; COBAS AMPLIPREP CYTOMEGALOVIRUS TEST; COBAS TAQMAN CYTOMEGALOVIRUS TEST; CONTROLLED STUDY; CYTOMEGALOVIRUS; EUROPE; IMMUNOCOMPROMISED PATIENT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNITED STATES; VIRUS EXAMINATION; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; EUROPE; HUMANS; IMMUNOCOMPROMISED HOST; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; UNITED STATES; VIRAL LOAD;

EID: 84872281120     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis900     Document Type: Article

References (21)

1. Gerna G, Lilleri D, Furione M, Baldani F. Management of human cytomegalovirus infection in transplantation: validation of virological cut-offs for preemptive therapy and immunological cut-offs for production. New Microbiol 2011; 34:229-54.
2. Humar A, Snydman D. Cytomegalovirus in solid organ transplant recipients. Am J Transpl 2009; 9(suppl 4):S78-86.
3. Fedorko DP, Yan SS. Recent advances in laboratory diagnosis of human cytomegalovirus infection. Clin Immunolog Revs 2002; 2:155-67.
4. Kotton CN, Kumar D, Caliendo AM, et al., Transplantation Society International CMV Consensus Group. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010; 7:779-95.
5. Boeckh M, Ljungman P. How I treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 2009; 113:5711-9.
6. Halfon P, Berger P, Khiri H, et al. Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantation. J Med Virol 2011; 83:490-5.
7. Preiksaitis JK, Brennan DC, Fishman J, Allen U. Canadian Society of Transplantation Consensus Workshop on Cytomegalovirus Management in Solid Organ Transplantation final report. Am J Transplant 2005; 5:218-27.
8. Andrews PA, Emery VC, Newstead C. Summary of British transplantation society guidelines for the prevention and management of CMV disease after solid organ transplantation. Transplantation 2011; 92:1181-7.
9. Pang XL, Fox JD, Fenton JM, Miller GG, Caliendo AM, Preiksaitis JK, for the American Society of Transplantation Infectious Diseases Community of Practice and the Canadian Society of Transplantation. Interlaboratory comparison of cytomegalovirus viral load assays. Am J Transplant 2009; 9:258-68.
10. Caliendo A, Shahbazian MD, Schaper C, et al. A commutable cytomegalovirus calibrator is required to improve the agreement of viral load values between laboratories. Clin Chem 2009; 55:1701-10.
11. Freyer JF, Heath AB, Anderson R, Minor PD, and the collaborative study group. Collaborative study to evaluate the proposed 1st WHO international standard for human cytomegalovirus for nucleic acid amplification-based assays. WHO/BS/10.2138, pp 1-40. Geneva, Switzerland, 18-22 October 2010.
12. Kraft CS, Armstrong WS, Caliendo AM. Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective. Clin Infect Dis 2012; 54:1793-7.
13. Roche Molecular Systems, Inc. COBAS TaqMan CMV Test FDA approved package insert. Branchburg, NJ: Roche, July 2012.
14. Clinical and Laboratory Standards Institute (CLSI). Metrological traceability and its implementation; a report. CLSI document X5-R, Vol 26, No 10. ISBN 1-56238-598-4.
15. Abbate I, Finnstrom N, Zaniratti S, et al. Evaluation of automated extraction system in combination with Affigene CMV tender for CMV DNA quantitative determination: comparison with nested PCR and pp65 antigen test. J Virol Meth 2008; 151:61-5.
16. Koidl C, Bozic M, Marth E, Kessler HH. Detection of CMV DNA: is EDTA whole blood superior to EDTA plasma? J Virol Meth 2008; 154:210-12.
17. Sia IG, Wilson JA, Espy MJ, Paya CV, Smith TF. Evaluation of the COBAS Amplicor CMV monitor test for detection of viral DNA in specimens taken from patients after liver transplantation. J Clin Microbiol 2000; 38:600-6.
18. Piiparinen H, Hockerstedt K, Gronhagen-Riska C, Lautenschlager I. Comparison of two quantitative CMV PCR tests, COBAS Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients. J Clin Virol 2004; 30:258-66.
19. Beckman C, Dumoulin A, Rinaldo CH, Hirsch HH. Comparison of a UL111a real-time PCR and pp65 antigenemia for the detection of ytomegalovirus. J Med Virol 2011; 83:2143-50.
20. Clinical Laboratory and Standards Institute (CLSI). EP9-A2. Method comparison and bias estimation using patient samples; approved guideline. 2nd ed. 2002.
21. Marty FM, Ljungman P, Papanicolaou GA, et al. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogenic stem cell transplants: a phase 3, double-blind, placebo-controlled, randomized trial. Lancet Infect Dis 2011; 11:284-92.